Advertisement

Topics

PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry

09:00 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
New Appointments Enhance PAREXEL’s Leadership and Expertise in Bringing Commercially Viable, Reimbursable Products to Market PAREXEL, a leading global biopharmaceutical services provider, today announced the appointment of...

Other Sources for this Article

PAREXEL Media Contacts:
Wendy Ryan
Tel.: +1 781-434-5104
Email: Wendy.Ryan@PAREXEL.com
or
Jenny Radloff, PAN Communications
Tel.: +1 617-502-4300
Email: PAREXEL@pancomm.com

NEXT ARTICLE

More From BioPortfolio on "PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...